Evaluation of adherence to therapy in patients of chronic kidney disease

被引:27
|
作者
Sontakke, Smita [1 ]
Budania, Ritu [1 ]
Bajait, Chaitali [1 ]
Jaiswal, Kavita [1 ]
Pimpalkhute, Sonali [1 ]
机构
[1] Govt Med Coll, Dept Pharmacol, Nagpur, Maharashtra, India
关键词
Medication nonadherence; morisky medication adherence questionnaire; polypharmacy in chronic kidney disease; MEDICATION; HEMODIALYSIS; PATTERNS;
D O I
10.4103/0253-7613.169597
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate adherence to medication and study factors associated with non-adherence in chronic kidney disease (CKD) patients. Methods: A prospective, cross-sectional, questionnaire based study was conducted in Nephrology department of a super specialty hospital. Patients above 18 years of age, suffering from CKD from six months or more were interviewed using self-designed, semi-structured questionnaire to get information about adherence to medication, diet restriction and lifestyle modification (n = 150). Morisky medication adherence questionnaire was used to calculate overall adherence. In this higher score indicates poor adherence. Main outcome measures included prevalence of non-adherence and factors associated with the same. Results: Average number of medicines taken by each patient was 8.0+1.612 (mean+SD) per day. Non-adherence to medication schedule was reported in 34% patients. Common causes of non-adherence were high cost (21.3%), complex dosing schedule (20%), fear of adverse effects (16%). Sixty-eight% patients were not aware about importance of taking each medicine. Sixteen% stopped taking medicines due to high cost. Forty-two% suggested that government should adopt measures to provide free medicines to poor patients. In Morisky medication adherence questionnaire high, medium and low adherence was reported in 7.3%, 55.3% and 37.3% of patients, respectively. Moderately positive correlation was observed between poor adherence and number of concurrent illnesses and number of medicines taken. Conclusion: Since majority of patients were not aware about importance of taking each medicine, creating awareness about the same is essential for improving adherence to therapy. Measures to provide free medicines to non-affording patients need to be implemented since high cost was other major cause of non-adherence.
引用
收藏
页码:668 / 671
页数:4
相关论文
共 50 条
  • [21] Adherence to drug therapy in kidney disease
    Magacho, E. J. C.
    Ribeiro, L. C.
    Chaoubah, A.
    Bastos, M. G.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2011, 44 (03) : 258 - 262
  • [22] NEPHROLOGICAL AWARNESS AND DRUG ADHERENCE IN PATIENTS WITH CHRONIC KIDNEY DISEASE ( CKD).
    Heleniak, Zbigniew
    Cieplinska, Magdalena
    Szychlinski, Tomasz
    Pryczkowska, Magdalena
    Bartosinska, Ewa
    Wiatr, Hanna
    Kotlowska, Hanna
    Tylicki, Leszek
    Rutkowski, BoleslAw
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 402 - 402
  • [23] A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease
    Tan, Jiaowang
    Luo, Li
    Zhang, Min
    Chen, Huifen
    Zhang, Dingjun
    Dong, Chendi
    Xia, Bingqing
    Fu, Lizhe
    Tang, Fang
    Liu, Xusheng
    Tan, Qinxiang
    Wu, Yifan
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 1487 - 1495
  • [24] Monitoring of adherence with nebulised therapy in patients with chronic lung disease
    Kastelik, JA
    Ojoo, JC
    Aziz, I
    Redington, AE
    Morice, AH
    THORAX, 2001, 56 : 73 - 73
  • [25] Adherence to Elastic Compression Therapy in Patients With Chronic Venous Disease
    Dominguez Calero, Andres F.
    Correa, Marta O.
    JOURNAL OF VASCULAR SURGERY, 2024, 79 (04) : 33S - 34S
  • [26] Evaluation of hepatosteatosis and gallstone disease in patients with chronic kidney disease
    Karahan, Dogu
    Sahin, Idris
    HEMODIALYSIS INTERNATIONAL, 2024, 28 (03) : 343 - 350
  • [27] Testosterone Replacement Therapy in Chronic Kidney Disease Patients
    Skiba, Ryszard
    Rymarz, Aleksandra
    Matyjek, Anna
    Dymus, Jolanta
    Wozniak-Kosek, Agnieszka
    Syrylo, Tomasz
    Zielinski, Henryk
    Niemczyk, Stanislaw
    NUTRIENTS, 2022, 14 (16)
  • [28] Tolvaptan therapy for edema in patients with chronic kidney disease
    Zhou, Li
    Xu, Qianqian
    Xi, Xuehua
    Yu, Xueying
    Li, Wenge
    CLINICAL NEPHROLOGY, 2024, 101 (06) : 308 - 316
  • [29] Osocimab as antithrombotic therapy in chronic kidney disease patients
    Heine, Gunnar Henrik
    Schneppe, Carolin
    NEPHROLOGIE, 2024, 19 (04): : 241 - 243
  • [30] Medication adherence evaluation in patients with chronic liver disease.
    Culafic, Milica
    Kovacevic, Sandra Vezmar
    Gosnjic, Nikola
    Filipovic, Marina
    Vucicevic, Katarina
    Miljkovic, Branislava
    Culafic, Djordje
    PHARMACOTHERAPY, 2017, 37 (06): : E45 - E45